611 W. Union Street
Benson, AZ 85602
(520) 586-0800

member support line
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line


611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...

Basic InformationLatest News
Should Cancer Survivors Be Prioritized for COVID Vaccine?Frozen Eggs Help Breast Cancer Survivors ConceiveWomen More Likely to Survive Lung Cancer After Surgery: StudyQuit Smoking, Your Bladder Will Thank YouMS Has Mixed Impact on Patients' Cancer Risk: StudyObamacare Boosts Colon Cancer Diagnosis, Care: StudyBlack Cancer Survivors Often Face Added Challenges: StudyWhen COVID Strikes Cancer Patients, Men Fare Worse'Hidden' Prostate Cancer on Biopsy Usually Means Good Outcome: StudyHormone Therapy for Prostate Cancer May Raise Heart RisksFamily Tragedy Has Mindy Kaling Speaking Out on Pancreatic CancerLung's Microbiome Might Play Role in Cancer'Watchful Waiting' OK for Black Men With Prostate CancerDelaying Cancer Care Costs LivesObamacare Cut Death Rates for 3 Major CancersColon Cancer Screening Should Start at Age 45: Task ForceDrug Combo May Be Safe, Effective Therapy for Rare LeukemiaHow to Care for Your Skin During Radiation TherapyWhat You Need to Know About Your Colon Cancer RiskMore Prostate Cancers Are Being Diagnosed at a Later StageMany Male Breast Cancers Diagnosed Late, and Delays Can Be LethalCancer Takes Heavy Toll on Women's Work and Finances: StudyDNA Analysis Might Reveal Melanoma RiskDrug Combo Approved for First-Line Treatment of MesotheliomaRadiation Plus Surgery May Be Best Against an Early Form of Breast CancerImmunotherapy Drug Boosts Survival for Lung Cancer PatientsWhat Foods, Medicines Can Lower Your Colon Cancer Risk?Breast Cancer Treatment Comes Later, Lasts Longer for Black WomenSmoking Reduces Survival Odds After Bladder Cancer SurgeryCertain Cancer Treatments May Heighten Danger From COVID-19Is an Early Form of Breast Cancer More Dangerous Than Thought?Immunotherapy Drug Boosts Survival With Bladder CancerMany High-Risk Patients Don't Know They Need Follow-Up ColonoscopyAlmost 90,000 Young American Adults Will Get Cancer This Year: ReportCoffee May Slow Spread of Colon CancerAHA News: Immune-Boosting Cancer Treatment May Pose Cardiovascular RiskWhy Do Black Men Still Fare Worse With Prostate Cancer?No Link Found Between Blood Pressure Meds and Cancer: StudyCatch Prostate Cancer Early – It Could Save Your Life'Spare Tire' Might Up a Man's Prostate Cancer RiskCancer Radiation Can Safely Proceed During COVID-19 Pandemic: StudyMany Thyroid Cancer Ultrasound Scans UnnecessaryCan Women With Early Breast Cancer Skip Post-Op Radiation?Delaying Prostate Cancer Radiation Won't Lower Survival OddsBetter Treatments Bring Better Survival After Lung CancerCould Daily Low-Dose Aspirin Hasten Cancer in Seniors?Many Older Americans Getting Cancer Screens They Don't Need: StudyCancer Diagnoses Plunge as Americans Avoid Screening During PandemicAggressive Cancer Diagnosed for First Time in a DinosaurFew U.S. Women Know About Cancer That Develops Near Breast Implants: Study
LinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Pain Management

Hormone Therapy for Prostate Cancer May Raise Heart Risks

HealthDay News
by By Dennis Thompson HealthDay Reporter
Updated: Nov 20th 2020

new article illustration

FRIDAY, Nov. 20, 2020 (HealthDay News) -- Hormone therapy can be a lifesaver for men with prostate cancer, but it also appears to put some at increased risk of heart problems, a new study reports.

Long-term androgen deprivation therapy (ADT) increased the risk of heart-related death nearly fourfold in a group of prostate cancer patients, and also caused their heart fitness to decrease, researchers found.

There is one important caveat: These patients were not in great shape to begin with. At the start of the study, 4 out of 5 men had two or more risk factors for heart disease, the study says.

"Our data are not suggesting that androgen deprivation therapy definitely causes worse heart health," said lead researcher Dr. Jingyi Gong, a clinical fellow with the Brigham and Women's Hospital Heart and Vascular Center in Boston. "Rather, it suggests that for folks who are sicker on baseline with multiple cardiac comorbidities, they are more likely to deteriorate with androgen deprivation therapy from a cardiopulmonary perspective."

Doctors treating prostate cancer patients with poor heart health need to be vigilant regarding heart-related side effects of ADT, said Dr. Bonnie Ky, editor-in-chief of JACC: CardioOncology, the journal in which the study appears.

"We need to do everything we can to ensure the patients can receive lifesaving cancer therapy in a safe manner," Ky said.

About 1 in every 9 men will be diagnosed with prostate cancer during their lifetime, researchers said in background notes. It is the second-leading cause of cancer death in American men.

ADT combined with radiation therapy is a standard treatment for prostate cancer, researchers note.

Prostate cancer is fueled by male hormones, which are called androgens. Drugs that block production of testosterone are used to lower androgen levels in the body, with the aim of stalling out the cancer.

Prolonged use of ADT in some patients has become more popular lately, in the wake of studies that showed keeping men on hormone therapy improves their cancer outcomes. But questions have arisen about the effects of long-term hormone therapy on heart health.

This study tracked the heart health of 616 prostate cancer patients as they received hormone therapy for nearly five years after their cancer diagnosis.

All had an exercise treadmill test at the beginning of the study to determine their initial heart fitness, as well as a thorough analysis of their heart risk factors.

From the start, nearly 82% of the men had two or more heart risk factors -- smoking, high cholesterol, diabetes, high blood pressure, excess weight, family history of heart problems, symptoms of heart disease, and the like.

About one-quarter of the men (150) received ADT before their first treadmill test, and 51 had been exposed to long-term hormone therapy. Most patients with prolonged exposure to hormone therapy (92%) had two or more risk factors for heart disease.

Researchers found that men on long-term ADT were 3.8 times more likely to die from heart-related illness during the five-year follow-up, and they were 2.7 times more likely to perform worse on subsequent treadmill tests.

Blocking male hormone production causes a number of changes to men's bodies that could promote bad heart health, Gong said.

Men tend to lose lean muscle mass and pack on excess weight in the form of fat when their testosterone levels drop, Gong said.

Their insulin resistance and cholesterol levels also can go haywire, Ky added.

"We postulate it's all these things" increasing heart risk among prostate cancer patients, Ky said. "These factors are each modifying the cardiovascular risk."

Prostate cancer patients can fight these effects by sticking to a heart-healthy lifestyle, Gong said. That includes regular exercise, eating right, quitting smoking, managing blood pressure and cholesterol, and losing weight.

"If the treatment is indicated from a cancer survival perspective, then at the very least these patients should be encouraged to stay physically active and manage their comorbidities such as hypertension and diabetes," Gong said.

More information

The American Heart Association has more on hormone therapy for prostate cancer.

SOURCES: Jingyi Gong, MD, clinical fellow, Brigham and Women's Hospital Heart and Vascular Center, Boston; Bonnie Ky, MD, editor-in-chief, JACC: CardioOncology; JACC: CardioOncology, Nov. 17, 2020